|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RAPID REPORT |
1 Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan
2 Molecular Genetics, Institute of Life Science, Kurume University, 2432-3 Aikawa, Kurume, Fukuoka, 839-0861, Japan
3 Department of Anaesthesiology, Kurume University School of Medicine, Asahimachi 67, Kurume, Fukuoka, 830-0011, Japan
Neuromedin U (NMU) is a braingut peptide first isolated from the spinal cord. Recent studies on NMU and its receptors have suggested a role of NMU in sensory transmission. Here we report on the localization of NMU in sensory neurones, and the actions of NMU in the substantia gelatinosa (SG) and the deep layer of the dorsal horn (laminae IIIV) in adult rat spinal cord slices using the patch-clamp technique. An immunohistochemical study revealed that NMU peptide was present in most of the dorsal root ganglion neurones. In the spinal cord, NMU-immunoreactive neurones were located in the deep layer (laminae IIIV), but not in the SG. However, NMU-positive axon terminals were observed in the SG as well as the deep layer. Bath-applied NMU (10 µM) increased the frequency, but not amplitude, of miniature excitatory postsynaptic currents (mEPSCs) in the SG and deep layer neurones by 146 ± 14% (P < 0.01, n= 17) and 174 ± 21% (P < 0.01, n= 6), respectively, without inducing any postsynaptic membrane currents recorded in tetrodotoxin. On the other hand, NMU did not affect miniature inhibitory postsynaptic currents recorded in tetrodotoxin. These findings, taken together, suggest that NMU acts on the presynaptic terminals of the primary afferent fibres working as an autocrine/paracrine neuromodulator to increase mEPSC frequency of the SG and deep layer neurones. This may account for the spinal mechanisms of the NMU-induced hyperalgesia reported previously.
(Received 15 June 2004;
accepted after revision 2 August 2004;
first published online 5 August 2004)
Corresponding author T. Katafuchi: Department of Integrative Physiology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashiku, Fukuoka 812-8582, Japan. Email: kataf{at}physiol.med.kyushu-u.ac.jp
This article has been cited by other articles:
![]() |
H. Zeng, A. Gragerov, J. G. Hohmann, M. N. Pavlova, B. A. Schimpf, H. Xu, L.-J. Wu, H. Toyoda, M.-G. Zhao, A. D. Rohde, et al. Neuromedin U Receptor 2-Deficient Mice Display Differential Responses in Sensory Perception, Stress, and Feeding Mol. Cell. Biol., December 15, 2006; 26(24): 9352 - 9363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moriyama, S. Fukuyama, H. Inoue, T. Matsumoto, T. Sato, K. Tanaka, I. Kinjyo, T. Kano, A. Yoshimura, and M. Kojima The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L971 - L977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moriyama, T. Sato, H. Inoue, S. Fukuyama, H. Teranishi, K. Kangawa, T. Kano, A. Yoshimura, and M. Kojima The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells J. Exp. Med., July 18, 2005; 202(2): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |